These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25046247)

  • 1. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.
    Zi FM; He JS; Li Y; Wu C; Wu WJ; Yang Y; Wang LJ; He DH; Yang L; Zhao Y; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
    Cancer Biol Ther; 2014 Oct; 15(10):1413-22. PubMed ID: 25046247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].
    Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):84-8. PubMed ID: 18315906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells.
    Kikuchi J; Koyama D; Mukai HY; Furukawa Y
    Int J Hematol; 2014 Jun; 99(6):726-36. PubMed ID: 24706190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines].
    Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):234-7. PubMed ID: 18843976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
    Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
    BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma.
    Perez LE; Parquet N; Meads M; Anasetti C; Dalton W
    Eur J Haematol; 2010 Mar; 84(3):212-22. PubMed ID: 19922463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
    Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
    Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.
    Chen L; Wang S; Zhou Y; Wu X; Entin I; Epstein J; Yaccoby S; Xiong W; Barlogie B; Shaughnessy JD; Zhan F
    Blood; 2010 Jan; 115(1):61-70. PubMed ID: 19837979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.
    Qiang YW; Hu B; Chen Y; Zhong Y; Shi B; Barlogie B; Shaughnessy JD
    Blood; 2009 Apr; 113(18):4319-30. PubMed ID: 19196662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
    Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
    Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
    Ge Y; Zhan F; Barlogie B; Epstein J; Shaughnessy J; Yaccoby S
    Br J Haematol; 2006 Apr; 133(1):83-92. PubMed ID: 16512833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation.
    Chung KM; Hsu SC; Chu YR; Lin MY; Jiaang WT; Chen RH; Chen X
    PLoS One; 2014; 9(2):e88772. PubMed ID: 24551161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis.
    Abdi J; Mutis T; Garssen J; Redegeld FA
    PLoS One; 2014; 9(5):e96608. PubMed ID: 24794258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteasome inhibitor induces apoptosis and influences the expression of Notch1 and NF-kappaB in multiple myeloma RPMI8226 cells].
    Wang H; Liu X; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):531-7. PubMed ID: 18549623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
    Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
    Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression.
    Hao M; Zhang L; An G; Meng H; Han Y; Xie Z; Xu Y; Li C; Yu Z; Chang H; Qiu L
    Leuk Lymphoma; 2011 Sep; 52(9):1787-94. PubMed ID: 21534877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade.
    Wen X; He X; Jiao F; Wang C; Sun Y; Ren X; Li Q
    Oncol Res; 2017 Apr; 25(4):629-640. PubMed ID: 27983931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.